Beverly Moy, MD, MPH

Publications

Morris PG, Chen C, Steingart RM, Fleisher M, Lin NU, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler MN, McArthur HL, Winer EP, Norton L, Hudis C, Dang CT.Troponin I and C-Reactive Protein are Commonly Detected in Patients with Breast Ca
21372222
Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K.Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].Plast Reconstr Surg. 2011 Jan;127(1):18-26.
21200195
Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C.Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amp
20479410
Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E.Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing.Qual Life Res. 2010 Apr;19(3):401-12.
20084464
Morris PG, Dickler M, McArthur HL, Traina T, Sugarman S, Lin N, Moy B, Come S, Godfrey L, Nulsen B, Chen C, Steingart R, Rugo H, Norton L, Winer E, Hudis CA, Dang CT.Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent shor
19901120
Sepucha KR,Ozanne EM,Partridge AH,Moy B.Is There a Role for Decision Aids in Advanced Breast Cancer?.Med Decis Making.;29(4):475-82.
19329775
Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR.Doctor-patient communication about advance directives in metastatic breast cancer.J Palliat Med. 2009 Jun;12(6):547-53.
19508141
Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD.Institutional academic industry relationships.JAMA. 2007 Oct 17;298(15):1779-86.
17940234
Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 May 24;16(10).
17525937
Moy B, Goss PE.Lapatinib-associated toxicity and practical management recommendations.Oncologist. 2007 Jul;12(7):756-65. Review.
17673607
Moy B, Goss PE.TEACH: Tykerb evaluation after chemotherapy.Clin Breast Cancer. 2007 Feb;7(6):489-92.
17386127
del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS.Mammographic breast density and race.AJR Am J Roentgenol. 2007 Apr;188(4):1147-50.
17377060
Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 Oct;16(10):895-903.
17245695
Moy B, Goss PE.Lapatinib: current status and future directions in breast cancer.Oncologist. 2006 Nov-Dec;11(10):1047-57. Review.
17110623
Moy B, Tu D, Pater JL, Ingle JN, Shepherd LE, Whelan TJ, Goss PE.Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.Ann Oncol. 2006 Nov;17(11):1637-43
16936184
Moy B, Goss PE.Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches.Clin Cancer Res. 2006 Aug 15;12(16):4790-3. Review.
16914563
Moy B, Park ER, Feibelmann S, Chiang S, Weissman JS.Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women.Psychooncology. 2006 Jul;15(7):623-34.
16304623
Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for do
16293865
Campbell EG, Moy B, Feibelmann S, Weissman JS, Blumenthal D.Institutional academic industry relationship: results of interviews with university leaders.Account Res. 2004 Apr-Jun;11(2):103-18.
15675051
Blanchard K, Colbert JA, Puri D, Weissman J, Moy B, Kopans DB, Kaine EM, Moore RH, Halpern EF, Hughes KS, Tanabe KK, Smith BL, Michaelson JS.Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.Cancer. 2004 Aug 1;101(3
15274062
Moy B, Wang JC, Raffel GD, Marcoux JP.Hemolytic uremic syndrome associated with clopidogrel: a case report.Arch Intern Med. 2000 May 8;160(9):1370-2.
10809043

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Beverly Moy, MD, MPH Publications Morris PG, Chen C, Steingart RM, Fleisher M, Lin NU, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler MN, McArthur HL, Winer EP, Norton L, Hudis C, Dang CT.Troponin I and C-Reactive Protein are Commonly Detected in Patients with Breast Ca 21372222 Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K.Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].Plast Reconstr Surg. 2011 Jan;127(1):18-26. 21200195 Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C.Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amp 20479410 Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E.Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing.Qual Life Res. 2010 Apr;19(3):401-12. 20084464 Morris PG, Dickler M, McArthur HL, Traina T, Sugarman S, Lin N, Moy B, Come S, Godfrey L, Nulsen B, Chen C, Steingart R, Rugo H, Norton L, Winer E, Hudis CA, Dang CT.Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent shor 19901120 Sepucha KR,Ozanne EM,Partridge AH,Moy B.Is There a Role for Decision Aids in Advanced Breast Cancer?.Med Decis Making.;29(4):475-82. 19329775 Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR.Doctor-patient communication about advance directives in metastatic breast cancer.J Palliat Med. 2009 Jun;12(6):547-53. 19508141 Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD.Institutional academic industry relationships.JAMA. 2007 Oct 17;298(15):1779-86. 17940234 Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 May 24;16(10). 17525937 Moy B, Goss PE.Lapatinib-associated toxicity and practical management recommendations.Oncologist. 2007 Jul;12(7):756-65. Review. 17673607 Moy B, Goss PE.TEACH: Tykerb evaluation after chemotherapy.Clin Breast Cancer. 2007 Feb;7(6):489-92. 17386127 del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS.Mammographic breast density and race.AJR Am J Roentgenol. 2007 Apr;188(4):1147-50. 17377060 Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 Oct;16(10):895-903. 17245695 Moy B, Goss PE.Lapatinib: current status and future directions in breast cancer.Oncologist. 2006 Nov-Dec;11(10):1047-57. Review. 17110623 Moy B, Tu D, Pater JL, Ingle JN, Shepherd LE, Whelan TJ, Goss PE.Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.Ann Oncol. 2006 Nov;17(11):1637-43 16936184 Moy B, Goss PE.Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches.Clin Cancer Res. 2006 Aug 15;12(16):4790-3. Review. 16914563 Moy B, Park ER, Feibelmann S, Chiang S, Weissman JS.Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women.Psychooncology. 2006 Jul;15(7):623-34. 16304623 Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for do 16293865 Campbell EG, Moy B, Feibelmann S, Weissman JS, Blumenthal D.Institutional academic industry relationship: results of interviews with university leaders.Account Res. 2004 Apr-Jun;11(2):103-18. 15675051 Blanchard K, Colbert JA, Puri D, Weissman J, Moy B, Kopans DB, Kaine EM, Moore RH, Halpern EF, Hughes KS, Tanabe KK, Smith BL, Michaelson JS.Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.Cancer. 2004 Aug 1;101(3 15274062 Moy B, Wang JC, Raffel GD, Marcoux JP.Hemolytic uremic syndrome associated with clopidogrel: a case report.Arch Intern Med. 2000 May 8;160(9):1370-2. 10809043
Site Map Site Feedback Web Privacy Policy